The COVID Project
The record
- Jurisdiction
- United States (federal); Drug Enforcement Administration, Diversion Control Division
- Level
- Federal
- Authority
- 21 U.S.C. 822(e); 21 C.F.R. 1301.12; 21 C.F.R. 1307.03
- Issued
- 2020-04-10 Apr. 10, 2020
- Effective
- 2020-04-10 (digitally signed Apr. 11, 2020) (read as 2020-04-10)
- End
- For the duration of the public health emergency (read as 2021-09-30)
- In force
- Apr. 10, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersOther
- Addressees
- DEA-registered hospitals and clinics
- manufacturers
- distributors
- Functions reached
- IP inpatient units and surge capacity
- SC supply chain
- ED emergency department
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
the Drug Enforcement Administration (DEA) has learned that some DEA-registered hospital/clinics need to utilize additional satellite hospital/clinic locations to accommodate the large influx of patients presenting for treatment.... To facilitate appropriate patient care and assist the nation in responding effectively to these unprecedented scenarios that have arisen during the COVID-19 pandemic, DEA is issuing this letter to provide DEA-registered hospital/clinics with the flexibility to utilize alternate satellite hospital/clinic locations under their current registration.
Enforcement
Registration requirements under 21 U.S.C. 822(e) and 842
Notes
Predicate for field hospitals, convention-center surge sites and hotel step-down units.